|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 144 studies with search of: | "Abacavir sulfate" [TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
|
||||
| 2 | Completed |
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
|
||||
| 3 | Unknown † |
Raltegravir Switch for Toxicity or Adverse Events
|
||||
| 4 | Unknown † |
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
|
||||
| 5 | Completed |
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
|
||||
| 6 |
Completed
Has Results |
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
|
||||
| 7 | Completed |
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
|
||||
| 8 | Unknown † |
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
|
||||
| 9 | Completed |
Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
|
||||
| 10 | Unknown † |
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
|
||||
| 11 | Unknown † |
A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
|
||||
| 12 | Terminated |
Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
|
||||
| 13 | Recruiting |
Treatment Options for Protease Inhibitor-exposed Children
|
||||
| 14 | Completed |
A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
|
||||
| 15 | Completed |
A Study of 1592U89 in HIV-Infected Children
|
||||
| 16 | Unknown † |
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
|
||||
| 17 | Completed |
The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors
|
||||
| 18 | Completed |
A Study of 1592U89 in HIV-Infected Adults
|
||||
| 19 | Completed |
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
|
||||
| 20 | Completed |
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|